Sign in
4

Changes in Ownership

Larimar Therapeutics, Inc. Filed Acc 0001209191-15-021905

Options or other derivatives

  • Chief Commercial Officer acquired 60,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Secor Alicia · Chief Commercial Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2015-02-27 Grant or award : show line 1 in the form Stock Option (Right to Buy) +60,000 $38.65 2025-02-27 60,000 219,235 D
Loading xslF345X03/doc4.xml…